<Suppliers Price>

Sodium Urate

Names

[ CAS No. ]:
1198-77-2

[ Name ]:
Sodium Urate

[Synonym ]:
Harnsaeure,Natrium-Salz
uric acid,sodium-salt
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-, sodium salt (1:1)
uric
SODIUM ACID URATE SODIUM SALT
SODIUM ACID URATE
MFCD00067310
uricacidsodium
URIC ACID MONOSODIUM SALT
Uric acid, monosodium salt
Monosodium Urate
Sodium 6,8-dioxo-6,7,8,9-tetrahydro-3H-purin-2-olate
Uric acid monosodium
Sodium Urate
3H-Purine-6,8-dione, 7,9-dihydro-2-hydroxy-, sodium salt (1:1)

Biological Activity

[Description]:

Uric acid sodium, scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress. Uric acid sodium can remove reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, inhibiting lipid peroxidation[1][2].

[Related Catalog]:

Research Areas >> Metabolic Disease

[Target]

Human Endogenous Metabolite


[In Vitro]

Uric acid (400 μM; 48 hours) protects Caco-2 cells from indomethacin-induced lipid peroxidation[2]. Co-treatment of cells with Indomethacin and Uric acid (200 μM IND plus 400 μM UA; 24 hours) significantly decreases ROS levels compared to those in cells incubated with indomethacin alone. Cell viability in Caco-2 cells treated with both Indomethacin and Uric acid (200 μM IND plus 400 μM UA; 24 hours) is higher than that in cells treated with indomethacin alone. Uric acid has a protective effect on indomethacin-induced intestinal cell changes through its antioxidant activity[2].

[In Vivo]

Uric acid (250 mg/kg; p.o.) ameliorates indomethacin-induced enteropathy[2]. Oral administration of uric acid decreased ROS accumulation in the ileum in a mouse model of indomethacin-induced enteropathy[2]. Animal Model: Eight-week-old male C57BL/6J mice[2] Dosage: 250 mg/kg body weight Administration: P.o. Result: When mice treated with indomethacin were concurrently administered uric acid orally, ulcer areas were significantly reduced, in a uric acid dose-dependent manner.

[References]

[1]. Yasutake Y, et al. Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity. J Gastroenterol Hepatol. 2017;32(11):1839-1845.

[2]. Wang Q, et al. Recent Progress on Uric Acid Detection: A Review. Crit Rev Anal Chem. 2020;50(4):359-375.

Chemical & Physical Properties

[ Molecular Formula ]:
C5H3N4NaO3

[ Molecular Weight ]:
190.092

[ Exact Mass ]:
190.010284

[ PSA ]:
117.46000

[ Stability ]:
Stable.

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YU7062000
CHEMICAL NAME :
Uric acid, monosodium salt
CAS REGISTRY NUMBER :
1198-77-2
LAST UPDATED :
199701
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C5-H3-N4-O3.Na
MOLECULAR WEIGHT :
190.11
WISWESSER LINE NOTATION :
T56 BMVM FMVMVJ &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
300 mg/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,289,1976 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X7188 No. of Facilities: 25 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1358 (estimated) No. of Female Employees: 956 (estimated)

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
YU7062000

[ HS Code ]:
2933990090

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Molecular Mechanisms Underlying Urate-Induced Enhancement of Kv1.5 Channel Expression in HL-1 Atrial Myocytes.

Circ. J. 79 , 2659-68, (2015)

Hyperuricemia induces endothelial dysfunction, oxidative stress and inflammation, increasing cardiovascular morbidities. It also raises the incidence of atrial fibrillation; however, underlying mechan...

Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment.

Biol. Pharm. Bull. 38(3) , 487-92, (2015)

Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide aden...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.